Imbruvica (ibrutinib)

pCPA File Number: 20896

Negotiation Status:

Concluded with an LOI

Indication(s):

Mantle Cell Lymphoma

Sponsor/Manufacturer:

Janssen Inc.

CDA-AMC Project Number:

PC0073-000

pCPA Engagement Letter Issued:

2016-08-12

Negotiation Process Concluded:

2017-06-27